Washington University School of Medicine — CureCurrent

How to interpret these research links

Connected source records

The exact organization name Washington University School of Medicine appears in 622 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Published trials622

Recruiting shown60

Roles2

SourceClinicalTrials.gov

Clinical trials

60 shown

Cognitive Neurocomputational Task Reliability & Clinical Applications Consortium (CNTRACS): Study 1NCT07853807 · lead sponsor · 2026-10-01

Precision Supplemental Imaging in Women With Dense BreastsNCT07277738 · lead sponsor · 2026-09-09

Low-Count Quantitative SPECT for Men Treated With Radium-223NCT07221825 · lead sponsor · 2026-09-01

HFrEF Polypill in Sri Lanka RCTNCT07569640 · lead sponsor · 2026-08-17

Brain Imaging and Immune Changes During Remibrutinib Treatment in Multiple Sclerosis.NCT07758270 · lead sponsor · 2026-08-15

DSP-0390 in Combination With Atezolizumab for Small Cell Lung CancerNCT07545954 · lead sponsor · 2026-08-03

First-Line Ipilimumab Plus Nivolumab and Nogapendekin Alfa Inbakicept (N-803) in Patients With Stage IV or Recurrent Non-Small Cell Lung CancerNCT07355205 · lead sponsor · 2026-07-07

Resources and Education for Addressing Chronic Health (REACH)NCT07819747 · lead sponsor · 2026-06-09

Multicontext Approach for Cognitive Function in Parkinson DiseaseNCT07190404 · lead sponsor · 2026-05-20

A Study to Find and Confirm Blood-based Markers (Called Proteins) That May Show Early Heart Changes in Women With Preeclampsia, Even Before Symptoms Appear, and the Use of Heart Ultrasound (Echocardiography) to Look at Patterns of How the Heart Changes During Pregnancy in Women With PreeclampsiaNCT07463898 · lead sponsor · 2026-04-24

Precision Imaging to Evaluate Kaposi SarcomaNCT06898203 · lead sponsor · 2026-04-10

CARE Tool Study Aim 3NCT07296887 · lead sponsor · 2026-04-08

Evaluating the Implementation and Effectiveness of the Pink and Pearl Campaign on Lung Cancer Screening at Christian HospitalNCT07146568 · lead sponsor · 2026-02-23

Healthy Behaviors for Insomnia Prevention in People With HIV and Ongoing PainNCT07270406 · lead sponsor · 2026-02-16

CHEST: A Collaboration With Community HEalth Centers to Implement SmarT for AsthmaNCT07241117 · lead sponsor · 2026-01-06

Small Cell Lung Cancer Irinotecan and CDC2-like Kinase Inhibition Trial (SLICK Trial)NCT07155200 · lead sponsor · 2025-12-18

Suubi4PrEP: Improving PrEP Access and Adherence Among Adolescent Girls and Young Women in UgandaNCT07002866 · lead sponsor · 2025-10-20

Effect of Ketone Esters on Liver Fat Content and Metabolic FunctionNCT07097506 · lead sponsor · 2025-09-26

This Study Involves a Positron Emission Tomography (PET) Scan Using a New Investigational Radioactive Tracer, [18F]-FZTA, to Detect Inflammation in the Brain. The Tracer Will be Tested in Healthy Younger Adults and Individuals With Multiple Sclerosis.NCT07115017 · lead sponsor · 2025-08-22

Propranolol for the Treatment of Kaposi Sarcoma in AdultsNCT06445166 · lead sponsor · 2025-08-20

Glucagon-like Peptide 1 (GLP-1) Receptor Agonist Therapy and Exercise Training in People With ObesityNCT07091500 · lead sponsor · 2025-08-11

Impact of an Electronic Health Record Maintenance Alert on PSA Screening Rates in a 10-Hospital Integrated Health SystemNCT07109427 · lead sponsor · 2025-08-11

Neuroimaging of Parkinson'sNCT07024875 · lead sponsor · 2025-08-01

WashU DIEP Flap Video and Patient Understanding ImprovementNCT06864754 · lead sponsor · 2025-07-18

Advancing Biopsychosocial Care Training InitiativeNCT07049861 · lead sponsor · 2025-07-14

ChatGPT & Surgeon Synergy: Redefining Breast Reconstruction Consultations for Enhanced Patient Engagement and SatisfactionNCT06981208 · lead sponsor · 2025-06-03

Just-In-Time Adaptive Interventions (JITAIs) in a Digital Mental Health Intervention for Middle-Aged and Older Adults With Chronic PainNCT06978166 · lead sponsor · 2025-06-02

Implementation and Effectiveness of the BJC-Pink and Pearl Project on Lung Cancer ScreeningNCT06898333 · lead sponsor · 2025-05-08

Ovarian-Sparing Adaptive Radiotherapy in Young Adult WomenNCT06904365 · lead sponsor · 2025-04-08

Personalized Cancer Vaccine (PCV) Strategy in Patients With Solid Tumors and Molecular Residual DiseaseNCT06529822 · lead sponsor · 2025-03-20

Role of KATP Channel Loss in Type 2 DiabetesNCT06830096 · lead sponsor · 2025-03-07

Zunsemetinib in Combination With Capecitabine in Patients With Hormone Receptor-Positive and HER2-Negative Metastatic Breast Cancer With Bone MetastasisNCT06374459 · lead sponsor · 2025-01-30

Mindfulness to Enhance Cognitive Health in Latino Older AdultsNCT07040904 · lead sponsor · 2024-12-10

A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic MutationNCT05552157 · lead sponsor · 2024-11-22

A Study of a Potential Disease Modifying Treatment in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic MutationNCT06647498 · lead sponsor · 2024-11-22

Evaluation of a Novel Technology to Support Tailored Health Behavior Counseling in Rural Primary Care ClinicsNCT06397729 · lead sponsor · 2024-11-01

Uterine Preservation Via Lifestyle TransformationNCT05903131 · lead sponsor · 2024-10-24

BettER: Biomarker Driven Early Therapeutic Selection in Patients With HR+ HER2- Metastatic or Unresectable Breast CancerNCT05977036 · lead sponsor · 2024-09-25

Ultra-Hypofractionated vs. Hypofractionated Radiation for Node-Positive Breast CancerNCT06559540 · lead sponsor · 2024-08-27

Adapting and Testing a Novel Digital Health Tool (PREVENT) to Improve Health Behavior Counseling and Cardiovascular Health in Rural Primary Care ClinicsNCT06063564 · lead sponsor · 2024-08-20

Study to Understand Novel Biomarkers in Researching DementiaNCT06547099 · lead sponsor · 2024-08-14

Efficacy and Safety of a Ketogenic Diet in Type 1 DiabetesNCT06503809 · lead sponsor · 2024-08-12

Improving Maternal Cardiovascular Outcomes Through the Implementation of a Hypertensive Disorders of Pregnancy Bundle in NigeriaNCT06859359 · lead sponsor · 2024-08-08

Smoldering Inflammation in MSNCT06591429 · lead sponsor · 2024-06-19

NeoTAILOR: ABiomarker-directed Approach to Guide Neoadjuvant Therapy for Patients With Stage II/III ER-positive, HER2-negative Breast CancerNCT05837455 · lead sponsor · 2024-05-30

Cryoablation vs Lumpectomy in T1 Breast CancersNCT05505643 · lead sponsor · 2024-04-03

Beta Amyloid PET Imaging for Alzheimer Disease With [18F]-FluselenamylNCT06439992 · lead sponsor · 2023-11-07

COOL-IT-PRO: Cryoablation of Breast Cancer in Non-surgical PatientsNCT05972343 · lead sponsor · 2023-07-26

Small Extracellular Vesicles and Insulin ActionNCT05933707 · lead sponsor · 2023-06-14

Investigation of Inflammation in Alzheimer's Disease and Related Dementias (ADRD) Using [11C]-CS1P1NCT06129838 · lead sponsor · 2023-05-05

The Inorganic Nitrate and eXercise Performance in Heart Failure (iNIX-HF)NCT05562167 · lead sponsor · 2023-03-31

Brain Health in Youth With Normal Weight, Overweight and Obesity at Risk for Type 2 Diabetes (T2D)NCT05277558 · lead sponsor · 2022-05-24

Treatment Monitoring of Patients Receiving CDK 4/6 Inhibitors for Hormone Receptor (HR) Positive, HER2 Negative Metastatic Breast Cancer (MBC) With or Without the Addition of DiviTum® Serum Thymidine Kinase 1 (TK1) Activity TestingNCT04968964 · lead sponsor · 2022-03-07

Depression and DrivingNCT05446805 · lead sponsor · 2021-06-17

Diffusion Basis Spectrum Imaging of the ProstateNCT04420702 · lead sponsor · 2020-02-27

Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid TumorsNCT04354064 · lead sponsor · 2019-05-29

Safety and Efficacy of 21 Gy, 23 Gy and 25 Gy for High Dose Rate (HDR) Prostate BrachytherapyNCT03424850 · lead sponsor · 2018-02-27

NMDA Receptor Antagonist Nitrous Oxide Targets Affective Brain CircuitsNCT02994433 · lead sponsor · 2017-01-27

Endocrine Treatment Alone for Elderly Patients With Estrogen Receptor Positive Operable Breast Cancer and Low Recurrence ScoreNCT02476786 · lead sponsor · 2017-01-17

Investigations of Dementia in Parkinson DiseaseNCT02763683 · lead sponsor · 2016-06-01

Drugs studied in this sponsor's trials

141 mapped RxNorm concepts

These drug records are connected through ClinicalTrials.gov studies listing Washington University School of Medicine as a sponsor, collaborator or responsible party. Each count is the number of distinct trials containing the mapped drug intervention. This does not establish that the organization manufactures, owns, sells or developed the drug.

Most studied mapped drug conceptsDistinct linked trials per RxNorm concept; one trial may study several drugs.

placebo34

paclitaxel8

carboplatin7

anastrozole5

docetaxel5

letrozole5

atezolizumab4

cisplatin4

placebo RxCUI 8375 · Lead sponsor in 22 linked trial(s) · 3 currently recruiting 34 trials paclitaxel RxCUI 56946 · Lead sponsor in 7 linked trial(s) · 0 currently recruiting 8 trials carboplatin RxCUI 40048 · Lead sponsor in 7 linked trial(s) · 0 currently recruiting 7 trials anastrozole RxCUI 84857 · Lead sponsor in 4 linked trial(s) · 2 currently recruiting 5 trials docetaxel RxCUI 72962 · Lead sponsor in 5 linked trial(s) · 0 currently recruiting 5 trials letrozole RxCUI 72965 · Lead sponsor in 5 linked trial(s) · 0 currently recruiting 5 trials atezolizumab RxCUI 1792776 · Lead sponsor in 4 linked trial(s) · 1 currently recruiting 4 trials cisplatin RxCUI 2555 · Lead sponsor in 4 linked trial(s) · 0 currently recruiting 4 trials cyclophosphamide RxCUI 3002 · Lead sponsor in 4 linked trial(s) · 0 currently recruiting 4 trials fulvestrant RxCUI 282357 · Lead sponsor in 4 linked trial(s) · 1 currently recruiting 4 trials goserelin RxCUI 50610 · Lead sponsor in 4 linked trial(s) · 1 currently recruiting 4 trials metformin RxCUI 6809 · Lead sponsor in 3 linked trial(s) · 0 currently recruiting 4 trials nivolumab RxCUI 1597876 · Lead sponsor in 3 linked trial(s) · 1 currently recruiting 4 trials pembrolizumab RxCUI 1547545 · Lead sponsor in 4 linked trial(s) · 0 currently recruiting 4 trials allopurinol RxCUI 519 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 3 trials aripiprazole RxCUI 89013 · Lead sponsor in 2 linked trial(s) · 0 currently recruiting 3 trials denosumab RxCUI 993449 · Lead sponsor in 3 linked trial(s) · 1 currently recruiting 3 trials doxorubicin RxCUI 3639 · Lead sponsor in 3 linked trial(s) · 0 currently recruiting 3 trials gemcitabine RxCUI 12574 · Lead sponsor in 3 linked trial(s) · 0 currently recruiting 3 trials irinotecan RxCUI 51499 · Lead sponsor in 2 linked trial(s) · 1 currently recruiting 3 trials lecanemab RxCUI 2626143 · Lead sponsor in 3 linked trial(s) · 0 currently recruiting 3 trials nitrous oxide RxCUI 7486 · Lead sponsor in 3 linked trial(s) · 1 currently recruiting 3 trials sitagliptin RxCUI 593411 · Lead sponsor in 3 linked trial(s) · 0 currently recruiting 3 trials aspirin RxCUI 1191 · Lead sponsor in 2 linked trial(s) · 0 currently recruiting 2 trials

Sponsor roles

lead sponsor520

collaborator102

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.